FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
QuidelOrtho Corporation Stock AnalysisComprehensive stock analysis for QuidelOrtho Corporation (QDEL) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisQDEL
QDEL
QuidelOrtho Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
QDEL
Home🔹Stocks🔹QuidelOrtho Corporation

QuidelOrtho Corporation

🇺🇸QDEL•NASDAQ

QuidelOrtho Corporation

🇺🇸QDEL•NASDAQ
Market cap
$803.29M
Sentiment

Your view on QDEL

Mkt Cap
$803.29M
Sentiment
Your view
QDEL
QuidelOrtho Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
QDEL
Company Overview

Overview

What the company does, where it operates, and who runs it.

About QuidelOrtho Corporation

Industry
Medical - Specialties
Sector
Healthcare
CEO
Brian J. Blaser
Headquarters
9975 Summers Ridge Road, San Diego, CA, US
Industry
Medical - Specialties
Sector
Healthcare
CEO
Brian J. Blaser
Headquarters
9975 Summers Ridge Road, San Diego, CA, US
Description

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units.

The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases.

The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems.

The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use.

It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for QuidelOrtho Corporation, and the rating behind it. QDEL last traded at $11.78; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for QuidelOrtho Corporation. Starting points for QuidelOrtho Corporation: EPS -$15.35, beta 0.68 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for QuidelOrtho Corporation. QuidelOrtho Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for QuidelOrtho Corporation. Trailing twelve-month EPS for QuidelOrtho Corporation stands at -$15.35. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for QuidelOrtho Corporation. QuidelOrtho Corporation has reported as a listed company since 1991. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

QuidelOrtho Corporation valued side by side against its closest peers. QuidelOrtho Corporation is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold QuidelOrtho Corporation, and how their positions are changing. At a $803.3M market value, institutional positions materially move QuidelOrtho Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by QuidelOrtho Corporation executives and directors. Shares of QuidelOrtho Corporation have traded between $19.50 and $49.45 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming QuidelOrtho Corporation. QuidelOrtho Corporation is a $803.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming QuidelOrtho Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for QuidelOrtho Corporation. Coverage tracks QuidelOrtho Corporation within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ATRC — AtriCure, Inc.
  • AZTA — Azenta, Inc.
  • EWTX — Edgewise Therapeutics, Inc.
  • GPCR — Structure Therapeutics Inc.
  • LMAT — LeMaitre Vascular, Inc.
  • NHC — National HealthCare Corporation
  • QURE — uniQure N.V.
  • TWST — Twist Bioscience Corporation

More Medical - Specialties companies

  • UEEC — United Health Products, Inc.
  • VFY.AX — Vitrafy Life Sciences Ltd.
  • VMTHF — Venus Medtech (Hangzhou) Inc.
  • WCUI — Wellness Center USA, Inc.
  • WOK — WORK Medical Technology Group Ltd.
  • YPHDF — Ypsomed Holding AG
  • ACAI — Safeplus International Holdings Limited
  • ADLI — American Medical Technologies Inc.
  • AIMV — AI Maverick Intel, Inc.
  • ALC — Alcon Inc.
  • ANIK — Anika Therapeutics, Inc.
  • APYX — Apyx Medical Corporation

ETFs holding QuidelOrtho Corporation

  • XHE — State Street SPDR S&P Health Care Equipment ETF (1.41%)
  • QQQS — Invesco NASDAQ Future Gen 200 ETF (0.48%)
  • PSCH — Invesco S&P SmallCap Health Care ETF (0.43%)
  • EKG — First Trust Nasdaq Lux Digital Health Solutions ETF (0.24%)
  • FFSM — Fidelity Fundamental Small-Mid Cap ETF (0.19%)

News

Latest Market News